OK, oops, its FINRA that does it,
but yea kid, keep concentrating on useless detail instead of admitting your were wrong all the way about NEURO-BIOTECH, now you have patent and TM to make your DD on and the only thing you do is only focusing on a little swap betwin SEC and FINRA ...
LOLOL
MRES is now a GOLD MINE, no R&D to finance, just selling some really needed product that are already in HIGHT demand all over the world !!!